JIN YANG PHARMACEUTICAL. CO., LTD
Founded in 1978 and listed on the KOSDAQ in 2000, Jin Yang Pharmaceutical is a generic-drug-focused pharmaceutical company producing Sobunal and Octiran.
Price
Change
Market cap
Products & technology
- Sobunal
- Octiran
Regulatory approvals
data.go.kr251 Korean MFDS drug approvals · 1987–2026 / 1 Korean MFDS device approvals · 2006
- MFDS drugSSenBQ ActB Tab.2026-07-14Drug · OTC · Notification202602029
- MFDS drugRosuvzet ODT. 10/5mg2026-06-30Drug · Prescription · Approval202601870
- MFDS drugRosuvzet ODT. 10/20mg2026-06-30Drug · Prescription · Approval202601871
- MFDS drugRosuvzet ODT. 10/10mg2026-06-30Drug · Prescription · Approval202601872
- MFDS drugEbicept Tab. 10/20mg2026-05-26Drug · Prescription · Approval202601506
- MFDS drugK-PRA Tab. 25mg2026-04-14Drug · Prescription · Approval202601067
- MFDS drugK-PRA Tab. 50mg2026-04-14Drug · Prescription · Approval202601068
- MFDS drugPitacholin SR Tab.2026-02-26Drug · Prescription · Approval202600584
- MFDS drugDentax Cap.2025-09-19Drug · OTC · Notification202502478
- MFDS drugJ-Proxen Tab.2025-05-27Drug · OTC · Notification202501303
- MFDS drugGynocalcium Tab2025-03-13Drug · OTC · Notification202500556
- MFDS drugRaivin Cap. 100mg2025-02-26Drug · Prescription · Approval202500420
Show 68 more
- MFDS drugRivin Cap. 200mg2025-02-26Drug · Prescription · Approval202500421
- MFDS drugRaivin Cap. 400mg2025-02-26Drug · Prescription · Approval202500422
- MFDS drugK smin Cap.2024-09-12Drug · OTC · Notification202402221
- MFDS drugAllegien Tab. 60mg2024-09-03Drug · OTC · Notification202402141
- MFDS drugAllegien Tab. 120mg2024-09-03Drug · OTC · Notification202402142
- MFDS drugJinkgo High Tab. 240mg2024-07-30Drug · OTC · Notification202401838
- MFDS drugSSenBQChondro Tab.2024-06-07Drug · OTC · Notification202401412
- MFDS drugChlo High Tab.2024-04-15Drug · OTC · Notification202400843
- MFDS drugNicergol Tab. 30mg(Nicergoline)2024-02-29Drug · Prescription · Approval202400444
- MFDS drugWonpyo Woohwangchungsimwon Suspension2023-10-31Drug · OTC · Notification202303038
- MFDS drugWonpyo Woohwangchungsimwon Liquid2023-10-31Drug · OTC · Notification202303039
- MFDS drugHemoheal2023-09-22Drug · OTC · Notification202302807
- MFDS drugEmpaglin Duo Tab. 12.5/850mg2023-09-14Drug · Prescription · Approval202302756
- MFDS drugEmpagreen Duo Tab. 12.5/500mg2023-09-14Drug · Prescription · Approval202302757
- MFDS drugEmpagreen Duo Tab. 12.5/1000mg2023-09-14Drug · Prescription · Approval202302758
- MFDS drugSSenBQ Tab.2023-09-11Drug · OTC · Notification202302710
- MFDS drugPROSEA Prefilled Inj.2023-08-16Drug · Prescription · Approval202302442
- MFDS drugARIA DS Tab.2023-08-10Drug · Prescription · Approval202302398
- MFDS drugBBN Tab.2023-05-25Drug · OTC · Notification202301678
- MFDS drugUrincool Cap.2023-04-18Drug · OTC · Notification202301269
- MFDS drugMecoMagBig Tab.2023-04-18Drug · OTC · Notification202301270
- MFDS drugBenfo B Power Tablet2023-04-05Drug · OTC · Notification202301146
- MFDS drugPiroxhigh gel2023-03-22Drug · OTC · Notification202300999
- MFDS drugDAPAGREEN-G TAB. 10/4mg2023-02-22Drug · Prescription · Approval202300664
- MFDS drugDAPAGREEN TAB. 10mg2023-01-31Drug · Prescription · Approval202300420
- MFDS drugDAPAGREEN TAB. 5mg2023-01-31Drug · Prescription · Approval202300421
- MFDS drugE Q Pen Kids A Syrup2023-01-30Drug · OTC · Notification202300373
- MFDS drugE Q Pen Kids I2023-01-11Drug · OTC · Notification202300213
- MFDS drugSSenBQM Tab.2022-07-04Drug · OTC · Notification202202769
- MFDS drugEmpagreenDuo Tab. 5/1000mg2022-04-04Drug · Prescription · Approval202201342
- MFDS drugEmpagreenDuo Tab. 5/850mg2022-04-04Drug · Prescription · Approval202201343
- MFDS drugEmpagreenDuo Tab. 5/500mg2022-04-04Drug · Prescription · Approval202201344
- MFDS drugTENEGREEN DUO SR TAB. 20/1000mg2022-04-04Drug · Prescription · Approval202201438
- MFDS drugTENEGREEN DUO SR TAB. 10/750mg2022-04-04Drug · Prescription · Approval202201439
- MFDS drugTENEGREEN DUO SR TAB. 10/500mg2022-04-04Drug · Prescription · Approval202201440
- MFDS drugJANUGREEN DUO TAB. 50/850mg2022-03-02Drug · Prescription · Approval202200910
- MFDS drugJANUGREEN DUO TAB. 50/500mg2022-03-02Drug · Prescription · Approval202200911
- MFDS drugJANUGREEN DUO TAB. 50/1000mg2022-03-02Drug · Prescription · Approval202200912
- MFDS drugDAPAGREEN-S TAB. 10/100mg2022-01-04Drug · Prescription · Approval202200065
- MFDS drugTENEGREEN TAB.2021-10-20Drug · Prescription · Approval202107033
- MFDS drugESZOL DUO TAB. 20/800mg2021-06-24Drug · Prescription · Approval202104835
- MFDS drugRecuvi Nuro Tab.Revoked2021-05-17Drug · OTC · Notification202103897
- MFDS drugEmpagreen Tab. 25mgRevoked2021-03-12Drug · Prescription · Approval202102263
- MFDS drugEmpagreen Tab. 10mgRevoked2021-03-12Drug · Prescription · Approval202102264
- MFDS drugJINTOZET TAB. 10/40mg2021-02-18Drug · Prescription · Approval202101407
- MFDS drugJINTOZET TAB. 10/20mg2021-02-18Drug · Prescription · Approval202101408
- MFDS drugJINTOZET TAB. 10/10mg2021-02-18Drug · Prescription · Approval202101409
- MFDS drugJinyang Naproxen Soft Cap.Revoked2020-11-24Drug · OTC · Notification202008137
- MFDS drugJinyang Nafamostat Mesilate Inj. 50mgRevoked2020-11-20Drug · Prescription · Approval202008085
- MFDS drugJinyang Nafamostat Mesilate Inj. 10mgRevoked2020-11-20Drug · Prescription · Approval202008086
- MFDS drugRecuvi EX Tab.Revoked2020-09-18Drug · OTC · Notification202006434
- MFDS drugJanugreen Tab. 25mg2020-08-20Drug · Prescription · Approval202005910
- MFDS drugJanugreen Tab. 50mg2020-08-20Drug · Prescription · Approval202005911
- MFDS drugJanugreen Tab. 100mg2020-08-20Drug · Prescription · Approval202005912
- MFDS drugRosuvzet Tab. 10/5mg2020-06-23Drug · Prescription · Approval202004602
- MFDS drugRosuvzet Tab. 10/10mg2020-06-23Drug · Prescription · Approval202004603
- MFDS drugRosuvzet Tab. 10/20mg2020-06-23Drug · Prescription · Approval202004604
- MFDS drugLaszol Cap. 15mgRevoked2020-05-26Drug · Prescription · Approval202003884
- MFDS drugLaszol Cap. 30mgRevoked2020-05-26Drug · Prescription · Approval202003885
- MFDS drugLinagreen Duo Tab. 2.5/1000mgRevoked2020-05-19Drug · Prescription · Approval202003651
- MFDS drugLinagreen Duo Tab. 2.5/850mgRevoked2020-05-19Drug · Prescription · Approval202003652
- MFDS drugLinagreen Duo Tab. 2.5/500mgRevoked2020-05-19Drug · Prescription · Approval202003653
- MFDS drugPrejin SR Cap. 100mgRevoked2020-05-08Drug · Prescription · Approval202003333
- MFDS drugPrejin SR Cap. 200mgRevoked2020-05-08Drug · Prescription · Approval202003334
- MFDS drugOlobica HCT Tab. 10/40/12.5mgRevoked2020-05-06Drug · Prescription · Approval202003283
- MFDS drugOlobica HCT Tab. 5/20/12.5mgRevoked2020-05-06Drug · Prescription · Approval202003284
- MFDS drugOlobica HCT Tab. 5/40/12.5mgRevoked2020-05-06Drug · Prescription · Approval202003285
- MFDS drugOlobica Tab. 10/40mgRevoked2020-04-24Drug · Prescription · Approval202003042
Showing the 80 most recent of 252 records.
Clinical trials
data.go.kr29 MFDS clinical trial authorisations · 2014–2026 (Bioequivalence 20 · Phase 1 8 · Phase 3 1)
- BioequivalenceJY6012026-08-04
1 trial site
- Phase 1JY5012026-05-29
1 trial site
- BioequivalenceJY4112026-01-02
1 trial site
- Phase 1JY4092025-11-17
2 trial sites
- Bioequivalence쎄클래신건조시럽125mg/5mL(클래리트로마이신)2025-07-16
2 trial sites
- Phase 1JY4092025-06-25
2 trial sites
- BioequivalenceJY4102025-06-12
2 trial sites
- Phase 1JY4082025-04-24
2 trial sites
- Bioequivalence쎄클래신건조시럽250mg/5mL(클래리트로마이신)2025-03-31
2 trial sites
- Phase 1JY4092025-03-20
2 trial sites
- Phase 1JY4082025-01-24
2 trial sites
- BioequivalenceJY4012024-03-11
2 trial sites
Show 17 more
- Phase 1JY3032024-02-06
1 trial site
- Phase 3JY3032023-11-20
6 trial sites
- Bioequivalence테라캡정50밀리그램2023-09-05
2 trial sites
- Bioequivalence암발탄정10/160밀리그램2022-02-22
2 trial sites
- Phase 1JY3022022-01-28
2 trial sites
- Bioequivalence테미스타정80/5밀리그램2021-12-28
2 trial sites
- Bioequivalence다파그린정10밀리그램2021-12-13
2 trial sites
- Bioequivalence암발탄정10/160밀리그램2021-04-29
2 trial sites
- Bioequivalence암발탄정10/160밀리그램2020-02-06
2 trial sites
- Bioequivalence아토브젯정10/40밀리그램2019-11-18
2 trial sites
- Bioequivalence진양 텔미사르탄/암로디핀베실산염정 80/5밀리그램2015-12-03
- Bioequivalence에스졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2015-11-26
3 trial sites
- Bioequivalence베스디핀정(암로디핀베실산염)2015-07-10
2 trial sites
- Bioequivalence모가톤정(이토프리드염산염)2015-07-08
2 trial sites
- Bioequivalence로수바틴정20밀리그램(로수바스타틴칼슘)2014-10-30
2 trial sites
- Bioequivalence아토란정20밀리그램2014-10-01
2 trial sites
- Bioequivalence쎄브렉스캡슐 200 밀리그램(세레콕시브)2014-07-07
2 trial sites
R&D and key agreements
Source: DART corporate disclosure제네릭 의약품 개발 및 제형 연구 · The Life Science Research Institute, located at the Seoul National University College of Pharmacy New Drug Development Center, develops generic drug products and conducts formulation stability research, staffed by 8 people including the director.
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed pharmaceutical company behind the world's first oral paclitaxel Liporaxel (DHP107) and the Amalian dermal filler.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Founded in 1976, Kyungdong Pharm produces prescription drugs including Duorovan and Baldipine, and launched the health-food brand WIAVIM.
Sinsin Pharmaceutical sells medicated patches and OTC medicines through direct deals with over 13,000 pharmacies nationwide.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition